{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T10:01:20Z","timestamp":1780653680896,"version":"3.54.1"},"reference-count":17,"publisher":"BMJ","issue":"10","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2017,10,4]]},"published-print":{"date-parts":[[2018,5]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Although guidelines support aortic valve replacement (AVR) in patients with severe aortic regurgitation (AR) and left ventricular ejection fraction (LVEF) &lt;50%, severe left ventricular dysfunction (LVEF &lt;35%) is thought to confer high surgical risk. We sought to determine if a survival benefit exists with AVR compared with medical management in this high-risk, relatively rare population.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A large institutional echocardiography database was queried to identify patients with severe AR and LVEF &lt;35%. Manual chart review was performed. Due to small sample size and population heterogeneity, corrected group prognosis method was applied, which calculates the adjusted survival curve for each individual using fitted Cox proportional hazard model. Average survival adjusted for comorbidities and age was then calculated using the weighted average of the individual survival curves.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Initially, 2\u200954\u2009614 echocardiograms were considered, representing 1\u200945\u2009785 unique patients, of which 40 patients met inclusion criteria. Of those, 18 (45.0%) underwent AVR and 22 (55.0%) were managed medically. Absolute mortality was 27.8% in the AVR group and 91.2% in the medical management group. After multivariate adjustment, end-stage renal disease (HR=17.633, p=0.0335) and peripheral arterial disease (HR=6.050, p=0.0180) were associated with higher mortality. AVR was associated with lower mortality (HR=0.143, p=0.0490). Mean follow-up time of the study cohort was 6.58 years, and mean survival for patients undergoing AVR was 6.31 years.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Even after adjustment for clinical characteristics and patient age, AVR is associated with higher survival for patients with low LVEF and severe AR. Although treatment selection bias cannot be completely eliminated by this analysis, these results provide some evidence that surgery may be associated with prolonged survival in this high-risk patient group.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/heartjnl-2017-312024","type":"journal-article","created":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T16:29:07Z","timestamp":1509553747000},"page":"835-840","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":37,"title":["Aortic valve replacement associated with survival in severe regurgitation and low ejection fraction"],"prefix":"10.1136","volume":"104","author":[{"given":"Amy G","family":"Fiedler","sequence":"first","affiliation":[{"name":"Division of Cardiac Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijeta","family":"Bhambhani","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Laikhter","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H","family":"Picard","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meagan M","family":"Wasfy","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Tolis","sequence":"additional","affiliation":[{"name":"Division of Cardiac Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serguei","family":"Melnitchouk","sequence":"additional","affiliation":[{"name":"Division of Cardiac Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thoralf M","family":"Sundt","sequence":"additional","affiliation":[{"name":"Division of Cardiac Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason H","family":"Wasfy","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,11,1]]},"reference":[{"key":"2025092002472104000_104.10.835.1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000038498.59829.38"},{"key":"2025092002472104000_104.10.835.2","doi-asserted-by":"crossref","unstructured":"Bonow R , Carabello B , Erwin J . \u00a02014 AHA \/ ACC Guideline for the management of patients with valvular heart disease: executive summary. 63;2014. 10.1161\/CIR.0000000000000029\/-\/DC1.","DOI":"10.1016\/j.jacc.2014.02.537"},{"key":"2025092002472104000_104.10.835.3","unstructured":"Eacts CS , Germany HB , Baro G , et al . Guidelines on the management of valvular heart disease (version 2012) The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European. 2012;2496:2451."},{"key":"2025092002472104000_104.10.835.4","first-page":"1","article-title":"ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"53","author":"Eacts","year":"20172017","journal-title":"Eur Journal Heart"},{"key":"2025092002472104000_104.10.835.5","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(80)90468-3"},{"key":"2025092002472104000_104.10.835.6","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.61.3.471"},{"key":"2025092002472104000_104.10.835.7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.athoracsur.2015.12.068","article-title":"Aortic regurgitation with markedly reduced left ventricular function is not a contraindication for aortic valve replacement","volume":"102","author":"Kaneko","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"2025092002472104000_104.10.835.8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.011541"},{"key":"2025092002472104000_104.10.835.9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.lungcan.2015.05.010","article-title":"Could less be more?-a systematic review and meta-analysis of sublobar resections versus lobectomy for non-small cell lung cancer according to patient selection","volume":"89","author":"Cao","year":"2015","journal-title":"Lung Cancer"},{"key":"2025092002472104000_104.10.835.10","unstructured":"Chambers K , Schulzer M , Sobolev B . A controlled trial of arthroscopic surgery for osteoarthritis of the knee. 2002;18:683\u20137 http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12240636"},{"key":"2025092002472104000_104.10.835.11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.12.1494"},{"key":"2025092002472104000_104.10.835.12","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a008670"},{"key":"2025092002472104000_104.10.835.13","first-page":"206","article-title":"Patient selection for transcatheter aortic valve implantation: An interventional cardiology perspective","volume":"1","author":"Mylotte","year":"2012","journal-title":"Ann Cardiothorac Surg"},{"key":"2025092002472104000_104.10.835.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0195-668X(03)00201-X"},{"key":"2025092002472104000_104.10.835.15","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.839787"},{"key":"2025092002472104000_104.10.835.16","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2318-8-1"},{"key":"2025092002472104000_104.10.835.17","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2014-000216"}],"updated-by":[{"DOI":"10.1136\/heartjnl-2017-312024corr1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T00:00:00Z","timestamp":1532563200000}}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2017-312024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:47:31Z","timestamp":1758361651000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2017-312024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,1]]},"references-count":17,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,4,26]]},"published-print":{"date-parts":[[2018,5]]}},"alternative-id":["10.1136\/heartjnl-2017-312024"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2017-312024","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,1]]}}}